Global Live Cell Imaging Market Report and Forecast 2024-2032

Global Live Cell Imaging Market Outlook

The global live cell imaging market attained a value of about USD 8.02 billion in 2023. The market is further expected to grow in the forecast period of 2024-2032 at a CAGR of 7.7% to reach nearly USD 15.69 billion by 2032.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Growing Stem Cell Research Activities is Catalysing the Market Growth of Live Cell Imaging

The increasing research activities regarding stem cell is surging the deployment of live cell imaging techniques to analyse location, purity, and numbers of cells and their components, therefore augmenting the market growth. As it is crucial to determine the interaction between stem cells and tissues during stem cell research, the deployment of live cell imaging techniques to precisely identify protein levels for optimal drug therapy is increasing. The introduction of various government initiatives to promote research and development (R&D) activities is further fuelling the growth of the live cell imaging industry. For instance, in March 2020, the Canadian government announced an investment of $6.9 million through the research funding program of the Stem Cell Network to support stem cell research activities in the country. Moreover, the rising utilisation of live cell imaging in the development of novel drugs is bolstering the market growth. The development of new technologies to enable the precision analysis of RNA, nucleic acid, proteins, and DNA, among others, is also increasing its demand in several diagnostic methods, which is propelling the market growth. In addition, the surge of various chronic diseases such as cancer is increasing the demand for live cell imaging in both diagnosis and treatment. The growing research and development (R&D) activities to observe the presence of cancer cells in bone marrow while enabling the identification of specific cancer cells are expected to provide further impetus to the market growth.

Live Cell Imaging: Market Segmentation

Live cell imaging refers to the study of live cells by deploying microscopy technologies to obtain images of live cells and tissues. It is crucial in various laboratory procedures in biological and biomedical research as it provides real-time and reliable information of cells and tissues, which makes it ideal for various applications such as stem cell research and regenerative medicine development.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

The major product types of live cell imaging are:

• Equipment
• Consumable 
• Software

The market can be broadly categorised on the basis of its applications into:

• Cell Biology
• Developmental Biology
• Stem Cell and Drug Discovery
• Others

By technology, the market is divided into:

• Time-Lapse Microscope
• Fluorescence Recovery After Photo-Bleaching (FRAP)
• Fluorescence Resonance Energy Transfer (FRET)
• High Content Screening (HCS)
• Others

The EMR report looks into the regional markets of live cell imaging like North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Technological Advancements to Bolster the Growth of the Live Cell Imaging Industry

As technological advancements are a major precursor of scientific research and development activities, technologies such as artificial intelligence (AI), deep learning, and 3D printing are increasingly integrated into live cell imaging techniques. The growing use of artificial intelligence (AI) enables the imaging of cells to be more precise, easier as well as time-efficient. Moreover, AI-based microscopy can identify and analyse small components of cells such as nuclei, hence aiding researchers analyse data rapidly and effectively. The deployment of AI-based microscopes also automates and enhances various functionality to quantify live cells and enable improved cell viability and faster image acquisitions. This is increasing the demand for such microscopes in research laboratories, which is invigorating the growth of the live cell imaging industry.

Furthermore, the rising use of 3D printing in various applications in medical and biological sciences is propelling the market growth. As air bubbles is a major issue in perfusion chambers deployed in live cell imaging, the demand for fluidic devices manufactured with 3D printing technology is significantly surging. In addition, the cost-effectiveness of 3D printing is enhancing the affordability of live cell imaging research activities, which is providing further impetus to the market growth. The development of portable and low-profile devices that can be directly mounted on optical microscopes to surge the precision of cell imaging is projected to propel the market growth for live cell imaging in the forecast period.

Key Industry Players in the Global Live Cell Imaging Market

The report presents a detailed analysis of the following key players in the global live cell imaging market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

• Carl Zeiss AG
• Leica Microsystems GmbH
• Nikon Instruments Inc.
• Becton, Dickinson and Company
• GE Healthcare
• Others

The comprehensive report looks into the macro and micro aspects of the industry. The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.

Key Highlights of the Report